{
  "ImplementationGuide/hl7.fhir.us.pq-cmc": {
    "history": false,
    "index": 0,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\ImplementationGuide-hl7.fhir.us.pq-cmc.json",
    "path": "ImplementationGuide-hl7.fhir.us.pq-cmc.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ImplementationGuide/hl7.fhir.us.pq-cmc",
    "version": "0.1.0",
    "name": "FHIR_pqcmc",
    "title": "PQ/CMC Mapping FHIR Implementation Guide",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "A guide to submitting PQ/CMC data for exchanged in FHIR resources.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsd",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Draft"
    }
  },
  "StructureDefinition/Base64DocumentReference": {
    "history": false,
    "index": 1,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-Base64DocumentReference.json",
    "path": "StructureDefinition-Base64DocumentReference.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/Base64DocumentReference",
    "version": "0.1.0",
    "name": "Base64DocumentReference",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "A profile that represents the document or diagram in base64.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-batch-analysis": {
    "history": false,
    "index": 2,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-batch-analysis.json",
    "path": "StructureDefinition-pqcmc-batch-analysis.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-batch-analysis",
    "version": "0.1.0",
    "name": "BatchAnalysis",
    "title": "Batch Analysis",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Batch or lot release testing  to ensure that pharmaceutical products meet the product specification.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-batch-formula": {
    "history": false,
    "index": 3,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-batch-formula.json",
    "path": "StructureDefinition-pqcmc-batch-formula.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-batch-formula",
    "version": "0.1.0",
    "name": "BatchFormula",
    "title": "Batch Formula",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Listing of all components of the dosage form to be used in the manufacture, their amounts on a per batch basis, including overages, and reference to their quality standards.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-batch-ingredient": {
    "history": false,
    "index": 4,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-batch-ingredient.json",
    "path": "StructureDefinition-pqcmc-batch-ingredient.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-batch-ingredient",
    "version": "0.1.0",
    "name": "BatchIngredient",
    "title": "Batch Ingredient",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Identifies the ingredients for the batch forumla",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-ComponentSubstance": {
    "history": false,
    "index": 5,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-ComponentSubstance.json",
    "path": "StructureDefinition-pqcmc-ComponentSubstance.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-ComponentSubstance",
    "version": "0.1.0",
    "name": "ComponentSubstance",
    "title": "Component Substance",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Any raw material intended for use int he manufacture of a drug substance, or any ingredient intended for use in the manufacture of a drug product including those that may not appear in such drug product.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-druproduct": {
    "history": false,
    "index": 6,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-druproduct.json",
    "path": "StructureDefinition-pqcmc-druproduct.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-druproduct",
    "version": "0.1.0",
    "name": "DrugProduct",
    "title": "Drug Product",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Includes the properties of the drug product, its components and impurities",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-Component": {
    "history": false,
    "index": 7,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-Component.json",
    "path": "StructureDefinition-pqcmc-Component.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-Component",
    "version": "0.1.0",
    "name": "DrugProductComponent",
    "title": "Drug Product Component",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "The amount detais about the drug product compoents to define the product composition in a product unit.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-ingredient": {
    "history": false,
    "index": 8,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-ingredient.json",
    "path": "StructureDefinition-pqcmc-ingredient.html",
    "url": "https://hl7.org/fhir/pq-cmc/StructureDefinition/prf-pqcmc-ingredient",
    "version": "0.1.0",
    "name": "DrugProductIngredient",
    "title": "Drug Product Ingredient",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "The amount detais about the drug product ingredients in the batch.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-drug-product-instance": {
    "history": false,
    "index": 9,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-drug-product-instance.json",
    "path": "StructureDefinition-pqcmc-drug-product-instance.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-drug-product-instance",
    "version": "0.1.0",
    "name": "DrugProductInstance",
    "title": "Drug Product Manufactured Instance",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Includes the properties of the drug product as manufactured.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-DrugSubstance": {
    "history": false,
    "index": 10,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-DrugSubstance.json",
    "path": "StructureDefinition-pqcmc-DrugSubstance.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-DrugSubstance",
    "version": "0.1.0",
    "name": "DrugSubstance",
    "title": "Drug Substance",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Drug Substance (Active Ingredient) nomenclature and characterizaiton",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-DrugSubstanceImpurity": {
    "history": false,
    "index": 11,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-DrugSubstanceImpurity.json",
    "path": "StructureDefinition-pqcmc-DrugSubstanceImpurity.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-DrugSubstanceImpurity",
    "version": "0.1.0",
    "name": "DrugSubstanceImpurity",
    "title": "Drug Substance Impurity",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Any component of the drug substance that is not the chemical entity.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-drug-substnace-instance": {
    "history": false,
    "index": 12,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-drug-substnace-instance.json",
    "path": "StructureDefinition-pqcmc-drug-substnace-instance.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-drug-substnace-instance",
    "version": "0.1.0",
    "name": "DrugSubstanceInstance",
    "title": "Drug Substance Manufactured Instance",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Includes the properties of the drug substance as manufactured.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-excipient": {
    "history": false,
    "index": 13,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-excipient.json",
    "path": "StructureDefinition-pqcmc-excipient.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-excipient",
    "version": "0.1.0",
    "name": "Excipient",
    "title": "Excipient Drug Substance",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Provides sufficient information  to identify an inactive substance and its source.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/MfgTestSiteOrganization": {
    "history": false,
    "index": 14,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-MfgTestSiteOrganization.json",
    "path": "StructureDefinition-MfgTestSiteOrganization.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/MfgTestSiteOrganization",
    "version": "0.1.0",
    "name": "MfgTestSiteOrganization",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "A profile for the data elements required to identify an organization that manufactures, processes or tests drug products or substances.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-PolymorphicForm": {
    "history": false,
    "index": 15,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-PolymorphicForm.json",
    "path": "StructureDefinition-pqcmc-PolymorphicForm.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-PolymorphicForm",
    "version": "0.1.0",
    "name": "PolymorphicForm",
    "title": "Polymorphic Form",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Alternate structure present inf the drug substance",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/PqAddress": {
    "history": false,
    "index": 16,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-PqAddress.json",
    "path": "StructureDefinition-PqAddress.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/PqAddress",
    "version": "0.1.0",
    "name": "PqAddress",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "pq-specific Constraints on the Address datatype dealing with US addresses.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmcQualitySpecification": {
    "history": false,
    "index": 17,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmcQualitySpecification.json",
    "path": "StructureDefinition-pqcmcQualitySpecification.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmcQualitySpecification",
    "version": "0.1.0",
    "name": "QualitySpecification",
    "title": "Quality Specification",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "A quality specificaion is for a drug product or drug substance (excipient, API or raw material.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-result-observation": {
    "history": false,
    "index": 18,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-result-observation.json",
    "path": "StructureDefinition-pq-result-observation.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-result-observation",
    "version": "0.1.0",
    "name": "RensultObservation",
    "title": "Result Observation",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Belgian profile for an observation in a laboratory report",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-routine-drug-product": {
    "history": false,
    "index": 19,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-routine-drug-product.json",
    "path": "StructureDefinition-pqcmc-routine-drug-product.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-routine-drug-product",
    "version": "0.1.0",
    "name": "RoutineDrugProduct",
    "title": "Drug Product",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Includes the identfying information of the drug product",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pqcmc-routine-drug-substance": {
    "history": false,
    "index": 20,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pqcmc-routine-drug-substance.json",
    "path": "StructureDefinition-pqcmc-routine-drug-substance.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pqcmc-routine-drug-substance",
    "version": "0.1.0",
    "name": "RoutineSubstanceDefinition",
    "title": "Brief Drug Substance",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Provides sufficient information  to identify a drug substance.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/SponsorOrganization": {
    "history": false,
    "index": 21,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-SponsorOrganization.json",
    "path": "StructureDefinition-SponsorOrganization.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/SponsorOrganization",
    "version": "0.1.0",
    "name": "SponsorOrganization",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "A profile for the data elements required to identify the sponsor of the drug products or substances.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-additional-info-extension": {
    "history": false,
    "index": 22,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-additional-info-extension.json",
    "path": "StructureDefinition-pq-additional-info-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-additional-info-extension",
    "version": "0.1.0",
    "name": "AditionalInformationExtension",
    "title": "Aditional Information",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Any additional information",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-container-closure-extension": {
    "history": false,
    "index": 23,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-container-closure-extension.json",
    "path": "StructureDefinition-pq-container-closure-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-container-closure-extension",
    "version": "0.1.0",
    "name": "ContainerClosureExtension",
    "title": "Container Closure",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "The packaging information including a brief description of the components, the assembled\r\npackaging system and any precautions needed to ensure the protection and preservation of the drug substance and drug product during their use in the clinical trials",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-content-percent-extension": {
    "history": false,
    "index": 24,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-content-percent-extension.json",
    "path": "StructureDefinition-pq-content-percent-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-content-percent-extension",
    "version": "0.1.0",
    "name": "ContentPercentExtension",
    "title": "Content (%)",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "The percentage of the component in the drug product.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/drug-product-manufacturing-batch": {
    "history": false,
    "index": 25,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-drug-product-manufacturing-batch.json",
    "path": "StructureDefinition-drug-product-manufacturing-batch.html",
    "url": "https://hl7.org/fhir/pq-cmc/StructureDefinition/extDrugProductMfgBatch",
    "version": "0.1.0",
    "name": "DrugProductmanufacturingBatch",
    "title": "Drug Product Manufacturing Batch",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "This profile defines the details of a batch of medicine.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-interpretation-code-extension": {
    "history": false,
    "index": 26,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-interpretation-code-extension.json",
    "path": "StructureDefinition-pq-interpretation-code-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-interpretation-code-extension",
    "version": "0.1.0",
    "name": "InterpretationCodeExtension",
    "title": "Interpretation Code",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "A code that describes how to relate the given value to an acceptance value.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-overage-extension": {
    "history": false,
    "index": 27,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-overage-extension.json",
    "path": "StructureDefinition-pq-overage-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-overage-extension",
    "version": "0.1.0",
    "name": "OverageExtension",
    "title": "Overage",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Amount and rationale for excess drug substance.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-quality-specification-extension": {
    "history": false,
    "index": 28,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-quality-specification-extension.json",
    "path": "StructureDefinition-pq-quality-specification-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-quality-specification-extension",
    "version": "0.1.0",
    "name": "QualitySpecificationExtension",
    "title": "Quality Specification Reference",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "The product specification used in the batch release or stability testing.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-quantity-batch-size": {
    "history": false,
    "index": 29,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-quantity-batch-size.json",
    "path": "StructureDefinition-pq-quantity-batch-size.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-quantity-batch-size",
    "version": "0.1.0",
    "name": "QuantityBatchSize",
    "title": "Batch Size",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "The quantity made by the batch formula.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-quantity-percent-extension": {
    "history": false,
    "index": 30,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-quantity-percent-extension.json",
    "path": "StructureDefinition-pq-quantity-percent-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-quantity-percent-extension",
    "version": "0.1.0",
    "name": "QuantityPercentExtension",
    "title": "Quantity Percent",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "The percentage of the component in the batch.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-rrt-extension": {
    "history": false,
    "index": 31,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-rrt-extension.json",
    "path": "StructureDefinition-pq-rrt-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-rrt-extension",
    "version": "0.1.0",
    "name": "RRTExtension",
    "title": "Relative Retention Time",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-specification-status-extension": {
    "history": false,
    "index": 32,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-specification-status-extension.json",
    "path": "StructureDefinition-pq-specification-status-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-specification-status-extension",
    "version": "0.1.0",
    "name": "SpecificationStatusExtension",
    "title": "Specification Status",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "The current FDA regulatory status of the specification. [Source: SME Defined]\nExamples: Approved, Not Approved, etc.\nNote: There are instances when FDA does approve the Specifications in a supplement or an amendment where other information in the dossier has not changed.  ",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-specification-type-extension": {
    "history": false,
    "index": 33,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-specification-type-extension.json",
    "path": "StructureDefinition-pq-specification-type-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-specification-type-extension",
    "version": "0.1.0",
    "name": "SpecificationTypeExtension",
    "title": "Specification type",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "A classification of specification related to the kind of the entity it is referencing. [Source: SME Defined]\nExamples:  Drug product, drug substance, etc.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-strength-operator-extension": {
    "history": false,
    "index": 34,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-strength-operator-extension.json",
    "path": "StructureDefinition-pq-strength-operator-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-strength-operator-extension",
    "version": "0.1.0",
    "name": "StrengthOperatorExtension",
    "title": "Strength Operator",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "A mathematical symbol that denotes equality or inequality between two values.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-strength-type-extension": {
    "history": false,
    "index": 35,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-strength-type-extension.json",
    "path": "StructureDefinition-pq-strength-type-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-strength-type-extension",
    "version": "0.1.0",
    "name": "StrengthTypeExtension",
    "title": "Strength Type  (for API)",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "A physical (contetn) of activity measurement of the strenght of the active ingredient.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-test-method-origin-extension": {
    "history": false,
    "index": 36,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-test-method-origin-extension.json",
    "path": "StructureDefinition-pq-test-method-origin-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-test-method-origin-extension",
    "version": "0.1.0",
    "name": "TestMethodOriginExtension",
    "title": "Test Method Origin",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "StructureDefinition/pq-order-extension": {
    "history": false,
    "index": 37,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\structuredefinition-pq-order-extension.json",
    "path": "StructureDefinition-pq-order-extension.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/StructureDefinition/pq-order-extension",
    "version": "0.1.0",
    "name": "TestOrderExtension",
    "title": "Test/Stage Order",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/PqActionRelationTypeVS": {
    "history": false,
    "index": 38,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-PqActionRelationTypeVS.json",
    "path": "ValueSet-PqActionRelationTypeVS.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/PqActionRelationTypeVS",
    "version": "0.1.0",
    "name": "PqActionRelationTypeVS",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcBatchUtilizationTerminology": {
    "history": false,
    "index": 39,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcBatchUtilizationTerminology.json",
    "path": "ValueSet-vsPqcmcBatchUtilizationTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcBatchUtilizationTerminology",
    "version": "0.1.0",
    "name": "PqcmcCBatchUtilizationTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to batch utilization in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcChemicalStructureDataFileOriginTerminology": {
    "history": false,
    "index": 40,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcChemicalStructureDataFileOriginTerminology.json",
    "path": "ValueSet-vsPqcmcChemicalStructureDataFileOriginTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcChemicalStructureDataFileOriginTerminology",
    "version": "0.1.0",
    "name": "PqcmcCChemicalStructureDataFileOriginTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to chemical structure data file origins in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcChemicalStructureDataFileTypeTerminology": {
    "history": false,
    "index": 41,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcChemicalStructureDataFileTypeTerminology.json",
    "path": "ValueSet-vsPqcmcChemicalStructureDataFileTypeTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcChemicalStructureDataFileTypeTerminology",
    "version": "0.1.0",
    "name": "PqcmcCChemicalStructureDataFileTypeTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to chemical structure data file types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcClosureTypeTerminology": {
    "history": false,
    "index": 42,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcClosureTypeTerminology.json",
    "path": "ValueSet-vsPqcmcClosureTypeTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcClosureTypeTerminology",
    "version": "0.1.0",
    "name": "PqcmcClosureTypeTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to closure types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcCoPackagedIndicatorTerminology": {
    "history": false,
    "index": 43,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcCoPackagedIndicatorTerminology.json",
    "path": "ValueSet-vsPqcmcCoPackagedIndicatorTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcCoPackagedIndicatorTerminology",
    "version": "0.1.0",
    "name": "PqcmcCoPackagedIndicatorTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to copackaged indicators in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcConformancetoCriteriaTerminology": {
    "history": false,
    "index": 44,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcConformancetoCriteriaTerminology.json",
    "path": "ValueSet-vsPqcmcConformancetoCriteriaTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcConformancetoCriteriaTerminology",
    "version": "0.1.0",
    "name": "PqcmcConformanceCriteriaTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to conformance to criteria in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcContainerOrientationTerminology": {
    "history": false,
    "index": 45,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcContainerOrientationTerminology.json",
    "path": "ValueSet-vsPqcmcContainerOrientationTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcContainerOrientationTerminology",
    "version": "0.1.0",
    "name": "PqcmcContainerOrientationTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to container orientation in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcContainerTypeTerminology": {
    "history": false,
    "index": 46,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcContainerTypeTerminology.json",
    "path": "ValueSet-vsPqcmcContainerTypeTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcContainerTypeTerminology",
    "version": "0.1.0",
    "name": "PqcmcContainerTypeTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to container types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcDrugProductComponentFunctionCategoryTerminology": {
    "history": false,
    "index": 47,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcDrugProductComponentFunctionCategoryTerminology.json",
    "path": "ValueSet-vsPqcmcDrugProductComponentFunctionCategoryTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcDrugProductComponentFunctionCategoryTerminology",
    "version": "0.1.0",
    "name": "PqcmcDrugProductComponentFunctionCategoryTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to drug product component function categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcDrugSubstanceProductIndicatorTerminology": {
    "history": false,
    "index": 48,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcDrugSubstanceProductIndicatorTerminology.json",
    "path": "ValueSet-vsPqcmcDrugSubstanceProductIndicatorTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcDrugSubstanceProductIndicatorTerminology",
    "version": "0.1.0",
    "name": "PqcmcDrugSubstanceProductIndicatorTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to drug substance product indicators in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcExcipientFunctionTerminology": {
    "history": false,
    "index": 49,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcExcipientFunctionTerminology.json",
    "path": "ValueSet-vsPqcmcExcipientFunctionTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcExcipientFunctionTerminology",
    "version": "0.1.0",
    "name": "PqcmcExcipientFunctionTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to excipient functions in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcImpurityClassificationTerminology": {
    "history": false,
    "index": 50,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcImpurityClassificationTerminology.json",
    "path": "ValueSet-vsPqcmcImpurityClassificationTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcImpurityClassificationTerminology",
    "version": "0.1.0",
    "name": "PqcmcImpurityClassificationTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to impurity classifications in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcInterpretationCodeTerminology": {
    "history": false,
    "index": 51,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcInterpretationCodeTerminology.json",
    "path": "ValueSet-vsPqcmcInterpretationCodeTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcInterpretationCodeTerminology",
    "version": "0.1.0",
    "name": "PqcmcInterpretationCodeTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to numeric interpretation codes in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcProcessRelatedImpurityCategoryTerminology": {
    "history": false,
    "index": 52,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcProcessRelatedImpurityCategoryTerminology.json",
    "path": "ValueSet-vsPqcmcProcessRelatedImpurityCategoryTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcProcessRelatedImpurityCategoryTerminology",
    "version": "0.1.0",
    "name": "PqcmcProcessRelatedImpurityCategoryTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to process related impurity categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcProductRelatedImpurityCategoryTerminology": {
    "history": false,
    "index": 53,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcProductRelatedImpurityCategoryTerminology.json",
    "path": "ValueSet-vsPqcmcProductRelatedImpurityCategoryTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcProductRelatedImpurityCategoryTerminology",
    "version": "0.1.0",
    "name": "PqcmcProductRelatedImpurityCategoryTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to product related impurity categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcQualityBenchmarkTerminology": {
    "history": false,
    "index": 54,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcQualityBenchmarkTerminology.json",
    "path": "ValueSet-vsPqcmcQualityBenchmarkTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcQualityBenchmarkTerminology",
    "version": "0.1.0",
    "name": "PqcmcQualityBenchmarkTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to quality benchmarks in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcSourceTypeTerminology": {
    "history": false,
    "index": 55,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcSourceTypeTerminology.json",
    "path": "ValueSet-vsPqcmcSourceTypeTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcSourceTypeTerminology",
    "version": "0.1.0",
    "name": "PqcmcSourceTypeTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to source types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcSpecificationStatusTerminology": {
    "history": false,
    "index": 56,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcSpecificationStatusTerminology.json",
    "path": "ValueSet-vsPqcmcSpecificationStatusTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcSpecificationStatusTerminology",
    "version": "0.1.0",
    "name": "PqcmcSpecificationStatusTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to specification statuses in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcSpecificationTypeTerminology": {
    "history": false,
    "index": 57,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcSpecificationTypeTerminology.json",
    "path": "ValueSet-vsPqcmcSpecificationTypeTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcSpecificationTypeTerminology",
    "version": "0.1.0",
    "name": "PqcmcSpecificationTypeTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to specification types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcSponsorIdentifierTypeTerminology": {
    "history": false,
    "index": 58,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcSponsorIdentifierTypeTerminology.json",
    "path": "ValueSet-vsPqcmcSponsorIdentifierTypeTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcSponsorIdentifierTypeTerminology",
    "version": "0.1.0",
    "name": "PqcmcSponsorIdentifierTypeTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to sponsor identifier types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcStorageConditionsTerminology": {
    "history": false,
    "index": 59,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcStorageConditionsTerminology.json",
    "path": "ValueSet-vsPqcmcStorageConditionsTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcStorageConditionsTerminology",
    "version": "0.1.0",
    "name": "PqcmcStorageConditionsTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to storage conditions in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcStrengthOperatorTerminology": {
    "history": false,
    "index": 60,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcStrengthOperatorTerminology.json",
    "path": "ValueSet-vsPqcmcStrengthOperatorTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcStrengthOperatorTerminology",
    "version": "0.1.0",
    "name": "PqcmcStrengthOperatorTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to strength operators in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcStrengthTypeTerminology": {
    "history": false,
    "index": 61,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcStrengthTypeTerminology.json",
    "path": "ValueSet-vsPqcmcStrengthTypeTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcStrengthTypeTerminology",
    "version": "0.1.0",
    "name": "PqcmcStrengthTypeTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to strength types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcTestCategoryTerminology": {
    "history": false,
    "index": 62,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcTestCategoryTerminology.json",
    "path": "ValueSet-vsPqcmcTestCategoryTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcTestCategoryTerminology",
    "version": "0.1.0",
    "name": "PqcmcTestCategoryTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to test categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcTestMethodOriginTerminology": {
    "history": false,
    "index": 63,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcTestMethodOriginTerminology.json",
    "path": "ValueSet-vsPqcmcTestMethodOriginTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcTestMethodOriginTerminology",
    "version": "0.1.0",
    "name": "PqcmcTestMethodOriginTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to test method origins in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcTestUsageTerminology": {
    "history": false,
    "index": 64,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcTestUsageTerminology.json",
    "path": "ValueSet-vsPqcmcTestUsageTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcTestUsageTerminology",
    "version": "0.1.0",
    "name": "PqcmcTestUsageTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to test usage in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcTestingSiteUniqueIdentifierTypeTerminology": {
    "history": false,
    "index": 65,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcTestingSiteUniqueIdentifierTypeTerminology.json",
    "path": "ValueSet-vsPqcmcTestingSiteUniqueIdentifierTypeTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcTestingSiteUniqueIdentifierTypeTerminology",
    "version": "0.1.0",
    "name": "PqcmcTestingSiteUniqueIdentifierTypeTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to testing site unique identifier types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsUnitsMeasure": {
    "history": false,
    "index": 66,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsUnitsMeasure.json",
    "path": "ValueSet-vsUnitsMeasure.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsUnitsMeasure",
    "version": "0.1.0",
    "name": "PqcmcUnitsMeasure",
    "title": "PQ/CMC Units of MeasureTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to units of measure in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcUnitsofMeasureTerminology": {
    "history": false,
    "index": 67,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcUnitsofMeasureTerminology.json",
    "path": "ValueSet-vsPqcmcUnitsofMeasureTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcUnitsofMeasureTerminology",
    "version": "0.1.0",
    "name": "PqcmcUnitsMeasureTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to units of measure in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsPqcmcValidationParameterTerminology": {
    "history": false,
    "index": 68,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsPqcmcValidationParameterTerminology.json",
    "path": "ValueSet-vsPqcmcValidationParameterTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsPqcmcValidationParameterTerminology",
    "version": "0.1.0",
    "name": "PqcmcValidationParameterTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used to qualify the information pertaining to validation parameters in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsSplDrugRouteofAdministrationTerminology": {
    "history": false,
    "index": 69,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsSplDrugRouteofAdministrationTerminology.json",
    "path": "ValueSet-vsSplDrugRouteofAdministrationTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsSplDrugRouteofAdministrationTerminology",
    "version": "0.1.0",
    "name": "SplDrugRouteofAdministrationTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "erminology used for representation of the information on pharmaceutical product route of administration in the framework of the Structured Product Labeling documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "ValueSet/vsSPLPharmaceuticalDosageFormTerminology": {
    "history": false,
    "index": 70,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\valueset-vsSPLPharmaceuticalDosageFormTerminology.json",
    "path": "ValueSet-vsSPLPharmaceuticalDosageFormTerminology.html",
    "url": "http://hl7.org/fhir/us/pq-cmc/ValueSet/vsSPLPharmaceuticalDosageFormTerminology",
    "version": "0.1.0",
    "name": "SplPharmaceuticalDosageFormTerminology",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Terminology used for representation of the information on pharmaceutical product dosage form in the framework of the SPL documents.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  },
  "CodeSystem/codesystemPqcmcCompSectionTypes": {
    "history": false,
    "index": 71,
    "source": "C:\\FHIR-us-pq-cmc\\fsh-generated\\resources\\codesystem-codesystemPqcmcCompSectionTypes.json",
    "path": "CodeSystem-codesystemPqcmcCompSectionTypes.html",
    "url": "http://hl7.org/fhir/pq-cmc/codesystem/SectionType",
    "version": "0.1.0",
    "name": "PqcmcCompSectionTypes",
    "experimental": false,
    "date": "2022-03-10T00:19:40-05:00",
    "description": "Classification of a sections of a PQ/CMC composition/document generally based on eCTD Module 3 section numbering for product and substance. A composition can have many section codes.",
    "jurisdictions": [
      {
        "code": "US",
        "name": "United States of America"
      }
    ],
    "status": {
      "class": "colsi",
      "owner": "Biomedical Research and Regulatory WG",
      "link": "http://www.hl7.org/Special/committees/rcrim/index.cfm",
      "status": "Active"
    }
  }
}